Mesenchymal Stem Cells Derived and Cultured from Glioblastoma Multiforme Increase Tregs, Downregulate Th17, and Induce the Tolerogenic Phenotype of Monocyte-Derived Cells

<div>Differentiation of GB-MSCs in osteogenic direction. Proven by quantification of alkaline phosphatase activity (a), von Kossa (b), and alizarin red staining (c). Control cells cultured in noninductive media (d).</div>

Stem Cells International

fig2

Figure 2

Figure 2: Mesenchymal Stem Cells Derived and Cultured from Glioblastoma Multiforme Increase Tregs, Downregulate Th17, and Induce the Tolerogenic Phenotype of Monocyte-Derived Cells 

Figure 2 | Mesenchymal Stem Cells Derived and Cultured from Glioblastoma Multiforme Increase Tregs, Downregulate Th17, and Induce the Tolerogenic Phenotype of Monocyte-Derived Cells 